Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Edgardo Gerszten, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Robert Gerszten and James Januzzi.
Robert Gerszten
Connection Strength
0.128
James Januzzi
  1. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol. 2014 Mar 04; 63(8):809-16.
    View in: PubMed
    Score: 0.035
  2. Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure. FASEB J. 2013 May; 27(5):1928-38.
    View in: PubMed
    Score: 0.033
  3. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012 Sep 01; 5(5):596-603.
    View in: PubMed
    Score: 0.032
  4. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011 May 01; 107(9):1375-80.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.